Ilsung Is Co., Ltd.

KOSE:A003120 Stock Report

Market Cap: ₩111.4b

Ilsung Is Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Seok-geun Yoon

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership46.1%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

Feb 20
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?

Jan 16
Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?

Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like

Dec 18
Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like

Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

Nov 21
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

CEO

Seok-geun Yoon (68 yo)

no data

Tenure

Mr. Seok-geun Yoon is an insider at Ilsung Is Co., Ltd. (formerly known as Ilsung Pharmaceuticals Co., Ltd.) and serves as its Chairman and serves as its Chief Executive Officer and served as its Vice Chai...